Total anomalous pulmonary venous connection risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:Total anomalous pulmonary venous connection}} | {{Template:Total anomalous pulmonary venous connection}} | ||
{{CMG}}; {{AE}} {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu] [[Priyamvada Singh|Priyamvada Singh, MBBS]] | {{CMG}}; {{AE}} {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; [[Priyamvada Singh|Priyamvada Singh, MBBS]][mailto:psingh13579@gmail.com]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu] | ||
==Overview== | ==Overview== | ||
There are certain factors that increase the risk of congenital heart diseases. | There are certain factors that increase the [[risk]] of congenital heart diseases, including maternal [[obesity]], [[medication]] during pregnancy, [[alcohol]] and drugs, [[rubella]] during pregnancy, [[diabetes]] during pregnancy, and [[genetic]] factors. | ||
==Risk Factors== | |||
Risk factors during congenital heart diseases are:<ref name="Alvarado-TerronesPerea-Cabrera2018">{{cite journal|last1=Alvarado-Terrones|first1=Evelyn G.|last2=Perea-Cabrera|first2=Maryangel|last3=Klünder-Klünder|first3=Miguel|last4=Segura-Stanford|first4=Begoña|last5=Erdmenger-Orellana|first5=Julio R.|last6=Lopez-Yañez Blanco|first6=Arturo|last7=Hernández-Carbajal|first7=Elizabeth|last8=Granados Riverón|first8=Javier T.|last9=Mejía-Marín|first9=Leonardo J.|last10=Balderrabano-Saucedo|first10=Norma A.|last11=Contreras-Ramos|first11=Alejandra|last12=Díaz-Rosas|first12=Guadalupe|last13=Sánchez-Urbina|first13=Rocío|title=Maternal Obesity as a Risk Factor for the Development of Total Anomalous Pulmonary Venous Connection in Their Offspring|journal=Archives of Medical Research|volume=49|issue=2|year=2018|pages=109–113|issn=01884409|doi=10.1016/j.arcmed.2018.06.001}}</ref><ref name="Correa-VillaseñorFerencz1991">{{cite journal|last1=Correa-Villaseñor|first1=Adolfo|last2=Ferencz|first2=Charlotte|last3=Boughman|first3=Joann A.|last4=Neill|first4=Catherine A.|title=Total anomalous pulmonary venous return: Familial and environmental factors|journal=Teratology|volume=44|issue=4|year=1991|pages=415–428|issn=0040-3709|doi=10.1002/tera.1420440408}}</ref><ref name="PhelanMcDermid2011">{{cite journal|last1=Phelan|first1=K.|last2=McDermid|first2=H.E.|title=The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)|journal=Molecular Syndromology|year=2011|issn=1661-8777|doi=10.1159/000334260}}</ref><ref name="BleylSaijoh2010">{{cite journal|last1=Bleyl|first1=Steven B.|last2=Saijoh|first2=Yukio|last3=Bax|first3=Noortje A.M.|last4=Gittenberger-de Groot|first4=Adriana C.|last5=Wisse|first5=Lambertus J.|last6=Chapman|first6=Susan C.|last7=Hunter|first7=Jennifer|last8=Shiratori|first8=Hidetaka|last9=Hamada|first9=Hiroshi|last10=Yamada|first10=Shigehito|last11=Shiota|first11=Kohei|last12=Klewer|first12=Scott E.|last13=Leppert|first13=Mark F.|last14=Schoenwolf|first14=Gary C.|title=Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms|journal=Human Molecular Genetics|volume=19|issue=7|year=2010|pages=1286–1301|issn=0964-6906|doi=10.1093/hmg/ddq005}}</ref><ref name="CluverMeyer2013">{{cite journal|last1=Cluver|first1=C.|last2=Meyer|first2=R.|last3=Odendaal|first3=H.|last4=Geerts|first4=L.|title=Congenital rubella with agenesis of the inferior cerebellar vermis and total anomalous pulmonary venous drainage|journal=Ultrasound in Obstetrics & Gynecology|volume=42|issue=2|year=2013|pages=235–237|issn=09607692|doi=10.1002/uog.12399}}</ref> | |||
* Maternal [[obesity]] | |||
* Medication during pregnancy | * Medication during pregnancy | ||
* [[Alcohol]] and drugs | * [[Alcohol]] and drugs | ||
* [[Rubella]] during pregnancy | * [[Rubella]] during pregnancy | ||
* [[Diabetes]] during pregnancy | * [[Diabetes]] during pregnancy | ||
* Genetic factors | * [[Genetic]] factors | ||
==References== | ==References== | ||
Latest revision as of 17:55, 9 April 2020
|
Total anomalous pulmonary venous connection Microchapters |
|
Differentiating Total anomalous pulmonary venous connection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Total anomalous pulmonary venous connection risk factors On the Web |
|
American Roentgen Ray Society Images of Total anomalous pulmonary venous connection risk factors |
|
FDA on Total anomalous pulmonary venous connection risk factors |
|
CDC on Total anomalous pulmonary venous connection risk factors |
|
Total anomalous pulmonary venous connection risk factors in the news |
|
Blogs on Total anomalous pulmonary venous connection risk factors |
|
Risk calculators and risk factors for Total anomalous pulmonary venous connection risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3]; Priyamvada Singh, MBBS[4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]
Overview
There are certain factors that increase the risk of congenital heart diseases, including maternal obesity, medication during pregnancy, alcohol and drugs, rubella during pregnancy, diabetes during pregnancy, and genetic factors.
Risk Factors
Risk factors during congenital heart diseases are:[1][2][3][4][5]
- Maternal obesity
- Medication during pregnancy
- Alcohol and drugs
- Rubella during pregnancy
- Diabetes during pregnancy
- Genetic factors
References
- ↑ Alvarado-Terrones, Evelyn G.; Perea-Cabrera, Maryangel; Klünder-Klünder, Miguel; Segura-Stanford, Begoña; Erdmenger-Orellana, Julio R.; Lopez-Yañez Blanco, Arturo; Hernández-Carbajal, Elizabeth; Granados Riverón, Javier T.; Mejía-Marín, Leonardo J.; Balderrabano-Saucedo, Norma A.; Contreras-Ramos, Alejandra; Díaz-Rosas, Guadalupe; Sánchez-Urbina, Rocío (2018). "Maternal Obesity as a Risk Factor for the Development of Total Anomalous Pulmonary Venous Connection in Their Offspring". Archives of Medical Research. 49 (2): 109–113. doi:10.1016/j.arcmed.2018.06.001. ISSN 0188-4409.
- ↑ Correa-Villaseñor, Adolfo; Ferencz, Charlotte; Boughman, Joann A.; Neill, Catherine A. (1991). "Total anomalous pulmonary venous return: Familial and environmental factors". Teratology. 44 (4): 415–428. doi:10.1002/tera.1420440408. ISSN 0040-3709.
- ↑ Phelan, K.; McDermid, H.E. (2011). "The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)". Molecular Syndromology. doi:10.1159/000334260. ISSN 1661-8777.
- ↑ Bleyl, Steven B.; Saijoh, Yukio; Bax, Noortje A.M.; Gittenberger-de Groot, Adriana C.; Wisse, Lambertus J.; Chapman, Susan C.; Hunter, Jennifer; Shiratori, Hidetaka; Hamada, Hiroshi; Yamada, Shigehito; Shiota, Kohei; Klewer, Scott E.; Leppert, Mark F.; Schoenwolf, Gary C. (2010). "Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms". Human Molecular Genetics. 19 (7): 1286–1301. doi:10.1093/hmg/ddq005. ISSN 0964-6906.
- ↑ Cluver, C.; Meyer, R.; Odendaal, H.; Geerts, L. (2013). "Congenital rubella with agenesis of the inferior cerebellar vermis and total anomalous pulmonary venous drainage". Ultrasound in Obstetrics & Gynecology. 42 (2): 235–237. doi:10.1002/uog.12399. ISSN 0960-7692.